Sorrento Competitors

OTC Stocks . USA . 
Stock . Sorrento Therape
SRNE Stock  USD 0  0.0007  28.00%   
Sorrento Therape competes with Delta Air, BCE, Nextplat Corp, Sphere Entertainment, and Socket Mobile; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Sorrento Therape competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Sorrento Therape to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Sorrento Therape Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Sorrento Therape competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.00028.78
Details
Intrinsic
Valuation
LowRealHigh
0.00028.78
Details

Sorrento Therape Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Sorrento Therape and its competitors represents the degree of relationship between the price movements of corresponding otcs. A correlation of about +1.0 implies that the price of Sorrento and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Sorrento Therape does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
SNCY
+ 0.84
DAL
NXPL
+ 0.8
BCE
VALN
+ 0.8
BCE
VALN
+ 0.65
NXPL
SCKT
+ 0.61
DAL
SNCY
+ 0.49
SCKT
  
High negative correlations   
VALN
- 0.9
DAL
BCE
- 0.89
DAL
SNCY
- 0.85
BCE
SCKT
- 0.74
BCE
NXPL
- 0.74
DAL
SCKT
- 0.7
NXPL

Risk-Adjusted Indicators

There is a big difference between Sorrento OTC Stock performing well and Sorrento Therape OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sorrento Therape's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Sorrento Therape Competitive Analysis

The better you understand Sorrento Therape competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Sorrento Therape's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Sorrento Therape's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
SRNE NOKFF DAL BCE NXPL SPHR SCKT VALN SNCY
 28.00 
 0 
Sorrento
 0.00 
 0.1 
Nok
 0.81 
 63.62 
Delta
 1.46 
 27.02 
BCE
 6.59 
 0.85 
Nextplat
 2.00 
 40.22 
Sphere
 0.66 
 1.50 
Socket
 1.00 
 3.96 
Valneva
 3.52 
 14.42 
Sun
Market Volatility
(90 Days Market Risk)
Out of control
Very steady
Very steady
Very steady
Abnormally volatile
Very steady
Dangerous
Somewhat reliable
Not too volatile
Market Performance
(90 Days Performance)
Insignificant
Very Weak
Solid
Very Weak
Very Weak
Very Weak
OK
Very Weak
OK
Odds of Financial Distress
(Probability Of Bankruptcy)
Very High
Quite High
Low
Below Average
Below Average
About Average
Average
High
About Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Fairly Valued
Under Valued
Fairly Valued
Over Valued
Over Valued
Under Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Strong Buy
Buy
Not Available
Buy
Not Available
Strong Buy
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Buy
Hold
Strong Sell
Cautious Hold
Strong Hold
Strong Sell
Strong Hold
Current Ratio
1.35
0.7
0.57
0.6
15.15
N/A
2.33
1.15
1.1
Net Asset
472.84 M
12.25 B
73.64 B
71.94 B
64.47 M
4.79 B
28.74 M
460.06 M
1.62 B
Profit Margin
N/A
-0.65
0.0771
0.011
-0.0759
-0.33
-0.0746
-0.0468
0.0425
EBITDA
(364.52 M)
1.04 B
8.78 B
9.76 B
(19.68 M)
(3.44 M)
(1.73 M)
(57.72 M)
226.24 M
Operating Margin
-5.11
-1.9
0.0845
0.25
-0.065
-0.45
-0.27
-0.27
0.0496
Current Valuation
129.17 M
486.63 M
61.46 B
53.8 B
4.19 M
2.4 B
15.42 M
361.55 M
1.29 B
Price To Book
4.01
N/A
3.03
2.43
0.98
0.62
0.64
1.41
1.38
Retained Earnings
(1.96 B)
N/A
5.65 B
(5.51 B)
(34.92 M)
11.39 M
(47.93 M)
(561.2 M)
94.23 M
Current Asset
71.84 M
N/A
9.06 B
4.81 B
N/A
N/A
5.17 M
N/A
N/A
Five Year Return
N/A
N/A
2.31
5.47
N/A
N/A
N/A
N/A
N/A
Beta
1.84
1.11
1.34
0.48
0.92
1.42
0.84
1.02
1.49
Number Of Employees
949
6
100 K
45.13 K
142
970
61
676
2.96 K
Shares Outstanding
551.28 M
3.73 B
645.28 M
912.28 M
25.96 M
28.93 M
7.61 M
81.18 M
52.94 M
Cash Flow From Operations
(293.86 M)
(47.97 M)
6.46 B
7.95 B
(3.6 M)
(19.66 M)
48.56 K
(202.74 M)
174.12 M
Annual Yield
N/A
N/A
0.0094
0.11
N/A
N/A
N/A
N/A
N/A
Total Debt
134.5 M
2.77 B
27.28 B
36.18 B
3.01 M
1.52 B
6.28 M
208.82 M
697.78 M
Return On Equity
-3.79
N/A
0.41
0.0155
-0.59
-0.16
-0.0753
-0.0396
0.0842
Return On Asset
-0.41
-0.17
0.0527
0.0488
-0.11
-0.0248
-0.0574
-0.11
0.0378
Number Of Shares Shorted
64.56 M
N/A
35.19 M
52.48 M
17.72 K
8.53 M
22.56 K
14.45 K
3.35 M
Book Value Per Share
-0.38
-2.25
21.29
15.48
1.72
64.69
2.36
1.55
10.44
Current Liabilities
36.04 M
N/A
17.53 B
9.99 B
N/A
N/A
4.01 M
N/A
N/A
Total Asset
472.84 M
12.25 B
73.64 B
71.94 B
64.47 M
4.79 B
28.74 M
460.06 M
1.62 B
Debt To Equity
1.51
N/A
6.96
1.37
0.05
N/A
0.27
1.43
1.3
Short Ratio
4.96
N/A
4.08
16.28
0.52
10.18
0.24
0.58
3.39
Target Price
13.0
N/A
73.56
48.0
N/A
50.75
1.25
15.85
19.13
Last Dividend Paid
N/A
N/A
0.5
3.96
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
0.03
N/A
80.47
43.23
4.78
93.8
3.42
1.16
95.4
Market Capitalization
2.21 M
354.27 M
41.05 B
24.65 B
22.07 M
1.44 B
11.03 M
321.82 M
763.39 M
Price To Earning
41.15
N/A
34.29
20.7
N/A
N/A
4.99
N/A
15.79
Price To Earnings To Growth
-0.07
N/A
39.29
5.09
N/A
N/A
N/A
N/A
0.61
Price To Sales
0.0343
0.16
0.68
1.01
0.33
1.27
0.62
2.03
0.72
Net Income
(577.76 M)
(1.44 B)
4.61 B
2.26 B
(3.78 M)
(200.65 M)
(1.92 M)
(101.43 M)
72.18 M
Earnings Per Share
-1.1
-0.053
7.21
0.06
-0.68
-11.23
-0.18
-0.13
0.83
Shares Owned By Insiders
0.8
N/A
0.26
0.01
56.92
6.2
32.83
N/A
4.6
Revenue
62.84 M
2.2 B
58.05 B
24.67 B
37.76 M
1.03 B
17.03 M
153.71 M
1.05 B
Working Capital
(231.55 M)
N/A
(16.15 B)
(4.21 B)
29.4 M
(507.98 M)
4.2 M
103.96 M
(147.23 M)
Cash And Equivalents
133.6 M
N/A
3.27 B
50 M
20.47 M
N/A
5.59 M
336.22 M
289.58 M
Cash Per Share
0.3
N/A
13.11
0.8
2.15
N/A
0.78
5.74
4.98
Gross Profit
(167.05 M)
(2.31 B)
9.68 B
10.47 B
1.86 M
233.3 M
10.37 M
(68.06 M)
245.38 M
Day Typical Price
0.0016
0.095
63.75
26.98
0.89
40.69
1.48
3.97
14.27
Accumulation Distribution
0.8
N/A
0.0182
0.0271
0.18
0.0416
0.0724
0.02
0.0333
Market Facilitation Index
0.002
N/A
1.17
0.74
0.18
1.74
0.11
0.08
0.48
Daily Balance Of Power
(0.35)
0.0
(0.44)
0.527
(0.33)
(0.47)
(0.09)
(0.50)
1.020833
Period Momentum Indicator
(0.0007)
N/A
(0.52)
0.39
(0.06)
(0.82)
(0.01)
(0.04)
0.49
Rate Of Daily Change
0.72
1.0
0.99
1.01
0.93
0.98
0.99
0.99
1.04
Day Median Price
0.0015
0.095
63.82
26.96
0.91
40.93
1.47
3.97
14.19
Price Action Indicator
(0.00005)
N/A
(0.46)
0.26
(0.09)
(1.12)
0.03
(0.03)
0.48
Coefficient Of Variation
2239.83
N/A
310.34
(422.72)
(1,141)
(1,094)
837.79
(266.20)
691.13
Mean Deviation
19.52
N/A
1.71
0.8825
3.08
2.12
2.08
1.9
2.63
Jensen Alpha
0.7402
N/A
0.5089
(0.38)
(0.44)
(0.42)
0.3707
(0.95)
0.3486
Total Risk Alpha
(3.02)
N/A
0.3642
(0.60)
(1.17)
(0.70)
(0.12)
(1.35)
(0.03)
Sortino Ratio
0.0453
N/A
0.3984
N/A
N/A
N/A
0.1008
N/A
0.1292
Downside Variance
635.78
N/A
2.1
N/A
N/A
N/A
8.76
N/A
8.64
Standard Deviation
28.41
N/A
2.18
1.51
4.89
2.85
3.55
2.55
3.49
Kurtosis
2.96
N/A
0.7938
18.48
13.54
1.04
9.2
0.7691
0.6314
Potential Upside
48.15
N/A
4.11
1.53
4.88
5.06
5.36
3.2
7.47
Treynor Ratio
0.2801
N/A
0.4352
(3.44)
(21.69)
(0.21)
1.11
7.78
0.3898
Maximum Drawdown
147.62
N/A
9.95
12.47
34.56
14.27
25.39
12.07
16.71
Variance
807.19
N/A
4.75
2.28
23.86
8.1
12.6
6.5
12.19
Market Risk Adjusted Performance
0.2901
N/A
0.4452
(3.43)
(21.68)
(0.20)
1.12
7.79
0.3998
Risk Adjusted Performance
0.0439
N/A
0.2534
(0.18)
(0.06)
(0.06)
0.0993
(0.28)
0.1187
Skewness
1.29
N/A
0.8379
(2.92)
(2.54)
0.2684
1.88
(0.48)
0.51
Semi Deviation
19.35
N/A
0.903
N/A
N/A
N/A
2.38
N/A
2.63
Information Ratio
0.0402
N/A
0.2647
(0.32)
(0.11)
(0.14)
0.084
(0.42)
0.1088
Value At Risk
(33.33)
N/A
(2.12)
(1.83)
(7.80)
(4.40)
(3.42)
(5.86)
(4.50)
Expected Short fall
(31.94)
N/A
(2.26)
N/A
N/A
N/A
(2.79)
N/A
(3.11)
Downside Deviation
25.21
N/A
1.45
N/A
N/A
N/A
2.96
N/A
2.94
Semi Variance
374.39
N/A
0.8155
N/A
N/A
N/A
5.65
N/A
6.9

Sorrento Therape Competition Performance Charts

Five steps to successful analysis of Sorrento Therape Competition

Sorrento Therape's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Sorrento Therape in relation to its competition. Sorrento Therape's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Sorrento Therape in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Sorrento Therape's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Sorrento Therape, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Sorrento Therape position

In addition to having Sorrento Therape in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Broad Commodities ETFs Thematic Idea Now

Broad Commodities ETFs
Broad Commodities ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Commodities ETFs theme has 26 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Commodities ETFs Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Sorrento OTC Stock

Sorrento Therape financial ratios help investors to determine whether Sorrento OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sorrento with respect to the benefits of owning Sorrento Therape security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY